Study of the Effects of Dopaminergic Medications on Dopamine Transporter Imaging in Parkinson's Disease
This study has been completed.
Sponsor:
Institute for Neurodegenerative Disorders
Collaborators:
Boehringer Ingelheim Pharmaceuticals
Information provided by:
Institute for Neurodegenerative Disorders
ClinicalTrials.gov Identifier:
NCT00096720
First received: November 12, 2004
Last updated: September 28, 2010
Last verified: May 2007
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | May 2007 |
| Estimated Primary Completion Date: | No date given |